Greiner Bio-One to invest HUF 2 bln in Hungary
Greiner Bio-One, an Austrian manufacturer of disposable health care products, said it will invest HUF 2 bln (€6.5 mln) in the construction of a new 2,000 square meters production hall at its site Mosonmagyaróvár, west Hungary. The project is scheduled to be completed by the beginning of 2017.
It will raise production space to 11,000 square meters. The development is expected to double the unit’s exports in three years, managing director László Balogh said. The investment will create up to 50 new jobs at the unit which employs 160 at present, he said. The company plans further developments from 2017 on, mainly in the field of logistics, Balogh said. Greiner Bio-One Hungary plans revenue of HUF 4.1 bln after HUF 3.6 bln in 2013 and projects revenue of HUF 3.9 bln in 2014.
Policymakers Cut Central Bank Base Rate by 50 bp to 7.75%
Bulgaria's Household Income, Spending Rise 20% in 2023
Spar Magyarország Revenue Climbs Close to 16% in 2023
Hungary Launches HUF 15 bln Tourism Sector Support Program
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
